Exacerbation of Sarcoidosis Following Interferon-alpha Therapy for Chronic Active Hepatitis C.
10.4046/trd.2006.61.3.285
- Author:
Hye Jung CHANG
1
;
Eun Hwa CHOI
;
In Je KIM
;
Yun Su SIM
;
Jin Hwa LEE
;
Tae Hun KIM
;
Jin Wook MOON
;
Eun Mi CHUN
;
Yoo Kyung KIM
;
Sun Hee SUNG
;
Jung Hyun CHANG
Author Information
1. Department of Internal Medicine, Ewha Women University College of Medicine, Seoul, Korea. jinhwalee@ewha.ac.kr
- Publication Type:Case Report
- Keywords:
Hepatitis C;
Interferon;
Sarcoidosis
- MeSH:
Adult;
Hepatitis C;
Hepatitis C, Chronic;
Hepatitis, Chronic*;
Humans;
Interferon-alpha*;
Interferons;
Ribavirin;
Sarcoidosis*;
Sarcoidosis, Pulmonary
- From:Tuberculosis and Respiratory Diseases
2006;61(3):285-288
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Interferon alpha is an immunomodulator that is used as an antiviral agent to treat chronic active viral hepatitis C. However, interferon can induce or exacerbate sarcoidosis. We report a case of 42-year-old man with an exacerbation of pulmonary sarcoidosis after the cessation of interferon and ribavirin therapy for chronic hepatitis C. The patient's sarcoidosis improved spontaneously and he continues to be monitored regularly without steroid therapy.
